STAT3 and diffuse large B-cell lymphoma: To confirm evidence that IL6 signaling is a critical driver of a subset of DLBCL and an indicator of engraftment and growth in NSG-IL6 mice [19], we treated U2932 and VAL cells with human IL6 and determined STAT3 activation.